Insights & Analysis

Industry insights that are curated and delivered to inform your dealmaking strategies. We select the most relevant information, providing a consistent, convenient source for exclusive intelligence and analysis.

Page 19

Activism

Activist Investing Today: Wachtell's Katz Discusses 13D Change

By Ronald Orol
|
Published: February 11th, 2022
David Katz, a top corporate defender, explains why he is excited that the nation’s securities regulator just issued new tougher transparency rules for activists that he has been pushing for over a decade.
M&A

Drinks With The Deal: Katten's Kimberly Smith

By David Marcus
|
Published: February 3rd, 2022
Kimberly Smith, head of the law firm's corporate department, discusses the current state of middle-market dealmaking, her work with family offices and increased regulatory scrutiny of even smaller deals.
Podcasts

Drinks With The Deal: Sidley's Justin Savage

By David Marcus
|
Published: January 20th, 2022
Justin Savage, co-head of the environmental and automotive and mobility groups at Sidley Austin, discusses his unconventional path to law firm practice, what he learned at the DOJ and how he talks to boards and management teams about environmental issues.
M&A

Drinks With The Deal: Covington's Catherine Dargan

By David Marcus
|
Published: January 6th, 2022
Covington head of M&A and corporate Catherine Dargan discusses building her healthcare M&A practice, current issues in healthcare dealmaking and her approaches to diversity and inclusion and associate retention in this week's podcast.
Activism

Drinks With The Deal: Eduardo Gallardo of Gibson Dunn

By David Marcus
|
Published: December 16th, 2021
Eduardo Gallardo, co-chair of M&A and chair of the activist defense group at Gibson Dunn, discusses the universal proxy, the Williams case and more on this week's Drinks With The Deal podcast.
Podcasts

Drinks With The Deal: Gregory Varallo of Bernstein Litowitz

By David Marcus
|
Published: December 9th, 2021
The Delaware partner discusses the switch from representing companies to working with shareholders, Andy Bouchard's achievements as chancellor, his love of hunting, poker and the American University of Rome and more in this week's episode.
Activism

Drinks With The Deal: Willkie's Tariq Mundiya

By David Marcus
|
Published: December 2nd, 2021
Willkie head of litigation Tariq Mundiya discusses the Williams poison pill case from earlier this year as well as the CytoDyn decision and the evolution of Delaware's Caremark doctrine in this week's Drinks With The Deal podcast.